Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUDS: Selzentry Switch in HIV+ Patients
NCT01866267Phase 4Completed
- Sponsor
- St. Hope Foundation
- Start
- Jan 2013
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of maraviroc in human immunodeficiency virus infection (HIV), sponsored by St. Hope Foundation. Started Jan 2013; status: completed.
02
Drugs
maraviroc
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01866267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01866267.